Amalgamated Bank’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $495K | Buy |
|
|||||
2025
Q1 | $510K | Sell |
|
|||||
2024
Q4 | $583K | Buy |
|
|||||
2024
Q3 | $502K | Sell |
|
|||||
2024
Q2 | $438K | Sell |
|
|||||
2024
Q1 | $574K | Sell |
|
|||||
2023
Q4 | $662K | Sell |
|
|||||
2023
Q3 | $645K | Sell |
|
|||||
2023
Q2 | $723K | Buy |
|
|||||
2023
Q1 | $805K | Sell |
|
|||||
2022
Q4 | $858K | Buy |
|
|||||
2022
Q3 | $800K | Buy |
|
|||||
2022
Q2 | $678K | Buy |
|
|||||
2022
Q1 | $756K | Sell |
|
|||||
2021
Q4 | $716K | Sell |
|
|||||
2021
Q3 | $670K | Sell |
|
|||||
2021
Q2 | $789K | Buy |
|
|||||
2020
Q1 | – | Sell |
|
|||||
2019
Q4 | $222K | Buy |
|
|||||
2019
Q3 | $255K | Sell |
|
|||||
2019
Q2 | $310K | Buy |
|
|||||
2019
Q1 | $277K | Buy |
|
|||||
2018
Q4 | $256K | Buy |
|
|||||
2018
Q3 | – | Sell |
|
|||||
2018
Q2 | $479K | Buy |
|
|||||
2018
Q1 | $320K | Sell |
|
|||||
2017
Q4 | $282K | Buy |
|
|||||
2017
Q3 | $262K | Sell |
|
|||||
2017
Q2 | $284K | Buy |
|